Public misinformed about seal of approval from US drug agency
Health • January 2014 • Views: 1,236
Efthimios Parasidis points out a serious flaw with how things are actually done at the FDA. This is kind of scary.
Between 2005 and 2011, nearly half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit, such as relieving disease symptoms, extending life, or improving someone’s ability to go about normal activities.